Cargando…
Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
Background: Due to poor diabetes self-management awareness as well as heavy patient burden, management of diabetes in India is challenging for clinicians. Digital therapeutics platforms provide accessible and cost-efficient care through evidence-based guidance for lifestyle and behavioural modificat...
Autores principales: | Singal, Arbinder, Verma, Ritika, Khader, Mohammed Abdul, Tanna, Snehal, Lakhani, Om, Chavan, Ravi, das, Rabindra, Modi, Alok, Patange, Sonali, Ranadive, Ruchira, Malde, Forum, Guntur, Saimala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067812/ http://dx.doi.org/10.4103/2230-8210.342262 |
Ejemplares similares
-
Abstract 140: Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on diabefly(®) digital therapeutics program using multidisciplinary approach
por: Singal, Chitra Selvan Arbinder, et al.
Publicado: (2022) -
Abstract 136: Video-based supervised exercise intervention successfully improves fitness in people with Type 2 diabetes: Outcomes from Diabefly(®) digital therapeutics platform
por: Singal, Arbinder, et al.
Publicado: (2022) -
Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days
por: Verma, Ritika, et al.
Publicado: (2022) -
Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
por: Joshi, Shilpa, et al.
Publicado: (2023) -
Abstract 63: A case report of friedreich ataxia (FA) associated with diabetes mellitus and hypertrophic cardiomyopathy “A tri prong approach in the management of insulin autoimmune syndrome”
por: Kumar, N S Praveen, et al.
Publicado: (2022)